Proxy Responses in Research on COVID-19 Among People With Intellectual and Developmental Disabilities.


Journal

American journal on intellectual and developmental disabilities
ISSN: 1944-7558
Titre abrégé: Am J Intellect Dev Disabil
Pays: United States
ID NLM: 101492916

Informations de publication

Date de publication:
01 Sep 2024
Historique:
received: 22 09 2023
accepted: 09 04 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 28 8 2024
Statut: ppublish

Résumé

Researchers and advocates have long called for improved research methods that better include people with intellectual and developmental disabilities (IDD), but challenges to doing so persist. Proxy responses are frequently used to circumvent some of these challenges, but may not fully capture the perspectives of people with IDD. The COVID-19 pandemic highlighted the possibility of consequences due to a lack of research about health outcomes for people with IDD, with documented disproportionate impact but little understanding about specific experiences for people with IDD. Using exploratory graph analysis (EGA) we explored the use of proxy responses on the COVID-19 Supplement of the National Core Indicators In-Person Survey. Findings suggest significant differences in response patterns between people who answered independently, via proxy, and with a mix of response types beyond what would be expected due to demographic differences in participants.

Identifiants

pubmed: 39197850
pii: 502857
doi: 10.1352/1944-7558-129.5.346
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

346-361

Informations de copyright

©AAIDD.

Auteurs

Sarah Lineberry (S)

Sarah Lineberry, Matthew Bogenschutz, and Michael Broda, Virginia Commonwealth University.

Matthew Bogenschutz (M)

Sarah Lineberry, Matthew Bogenschutz, and Michael Broda, Virginia Commonwealth University.

Michael Broda (M)

Sarah Lineberry, Matthew Bogenschutz, and Michael Broda, Virginia Commonwealth University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH